HDAC2 and inflammatory bowel disease: Future research could further explore the application of HDAC2 inhibitors in other chronic inflammatory diseases (such as inflammatory bowel disease) and develop specific therapeutic strategies targeting HDAC2 to improve patients' pain and quality of life.